| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 1, 2026 | Option exercise(M) | 58K | $10.36 | $605K | 124K |
| May 1, 2026 | Sell(S) | 37K | $53.52 | $2.0M | 87K |
| May 1, 2026 | Sell(S) | 21K | $54.04 | $1.1M | 66K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 1, 2026 | Option exercise(M) | 58K | — | $0 | 30K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001741533-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Kiniksa Pharmaceuticals International, plc
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.